Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › PBLS

FARALLON CAPITAL MANAGEMENT, L.L.C. position in PBLS

PARABILIS MEDICINES INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 2,368,200 shares of PBLS (PARABILIS MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$76.5M, representing 0.34% of its reported portfolio and ranking #36 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)2.37M sh
Reported value held$76.47M
Portfolio Weight0.34%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s PBLS position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in PBLS in Q2 2026 at 2,368,200 shares (US$64.8M). The position peaked in Q3 2026 at 2,368,200 shares, worth US$76.5M. Across 2 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,368,200 shares valued at US$76.5M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 2.37M $64.82M New
Q3 2026 2.37M $76.47M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PBLS and 13F data

PBLS (PARABILIS MEDICINES INC) is a Health Care company. 129 other funds we track also report a position in PBLS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$791.9M), ARCH Venture Management, LLC (US$175.5M), Alphabet Inc. (US$158.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PBLS

All PBLS fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held PBLS?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed PBLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in PBLS?

As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 2.37M shares of PBLS (PARABILIS MEDICINES INC), valued at $76.47M, representing 0.34% of its reported portfolio and ranking #36.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling PBLS?

In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in PBLS. The position peaked in Q3 2026 at 2.37M shares.

Which other funds hold PBLS?

Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, Alphabet Inc., among 129 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.